Protara Therapeutics (TARA) Total Non-Current Liabilities (2013 - 2016)

Protara Therapeutics (TARA) has 4 years of Total Non-Current Liabilities data on file, last reported at $4.8 million in Q3 2016.

• On a quarterly basis, Total Non-Current Liabilities rose 52.9% year-over-year to $4.8 million in Q3 2016; TTM through Sep 2016 was $4.8 million, a 52.9% increase from a year earlier, with the FY2015 full-year figure at $3.6 million, changed N/A from the prior year.
• Total Non-Current Liabilities for Q3 2016 stood at $4.8 million, up from $4.5 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for TARA reached as high as $8.3 million in Q4 2013 and fell as low as $2.7 million in Q3 2014.
• Historically, Total Non-Current Liabilities has averaged $4.1 million across 4 years, with a median of $3.4 million in 2015.
• Across the five-year window, Total Non-Current Liabilities grew 19.19% in 2015 and soared 62.64% in 2016, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $8.3 million in 2013, then sank by 68.07% to $2.7 million in 2014, then surged by 35.29% to $3.6 million in 2015, then soared by 34.71% to $4.8 million in 2016.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $4.8 million in Q3 2016, $4.5 million in Q2 2016, and $3.3 million in Q1 2016.